ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08531
-0,02%
Bitcoin
69.844,73
-0,41%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aclarion Inc (ACON)

  7. Aclarion Inc (ACON) News

ACON

Aclarion (ACON)

Aclarion Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ACON
DatumZeitQuelleÜberschriftSymbolFirma
25/04/202415h14GlobeNewswire Inc.Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONAclarion Inc
06/03/202422h09Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
04/03/202414h00GlobeNewswire Inc.Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsNASDAQ:ACONAclarion Inc
27/02/202421h22GlobeNewswire Inc.Aclarion Announces Closing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
27/02/202420h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
27/02/202416h46Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ACONAclarion Inc
27/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
26/02/202415h15GlobeNewswire Inc.Aclarion Announces Pricing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
23/02/202417h46Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
21/02/202423h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
21/02/202421h02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
06/02/202423h32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
05/02/202414h00GlobeNewswire Inc.Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic PartnershipNASDAQ:ACONAclarion Inc
02/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
01/02/202423h16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
31/01/202423h26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
29/01/202412h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
23/01/202415h53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
22/01/202422h48Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
22/01/202414h00GlobeNewswire Inc.Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDNASDAQ:ACONAclarion Inc
17/01/202414h00GlobeNewswire Inc.Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan SolutionNASDAQ:ACONAclarion Inc
12/01/202422h15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
08/01/202414h00GlobeNewswire Inc.Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of NociscanNASDAQ:ACONAclarion Inc
04/01/202414h01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
04/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
02/01/202418h00GlobeNewswire Inc.Aclarion Announces Reverse Stock SplitNASDAQ:ACONAclarion Inc
29/12/202312h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACONAclarion Inc
19/12/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
11/12/202322h55Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
27/11/202314h00GlobeNewswire Inc.Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNASDAQ:ACONAclarion Inc
 Showing the most relevant articles for your search:NASDAQ:ACON

Kürzlich von Ihnen besucht

COIN
DEFTEUR
BINA
KMDUSDT
Komodo
BIT
F08526
Vontobel Financial Produ...
NASDAQ
GNLX
Genelux
BOV
RBRX11
Rbr Plus Multiestrategia...
NYSE
AAM-A
Apollo Asset Management
COIN
AFINETH
Asian Fintech
COIN
BCHOLDGBP
LSE
HOGS
Wt Lean Hogs
NYSE
PDS
Precision Drilling
ASX
CBAHAM
Commonwealth Bank of Aus...
BIT
UV4LSG
UniCredit Bank
USOTC
APETF
Alphagen Intelligence (PK)
ASX
EP1
E&P Financial
BOV
MDIA3M
M.DIAS BRANCO ON
AMEX
AINC
Ashford
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten